How many Ayurvedic stocks are outperforming Nifty 500?
Currently, 1 stocks in the Ayurvedic sector are outperforming Nifty 500. This represents the sector's breadth — a higher count indicates broader sector participation in the market rally.
Weekly momentum analysis for Ayurvedic sector stocks outperforming Nifty 500.
Stocks in Ayurvedic outperforming Nifty 500 by 10%+ over 3 months. Rising trend = broader participation.
Sector in Leaders quadrant — broad participation + rising strength.
Added 1 stock this week. Participation improving.
New this week: Jeena Sikho Lifecare Ltd
Operating margins volatile across 1 stock — earnings quality uneven, watch for stabilization.
Based on: Profit Growth, Margins, Cash Flow, Valuations
Only 0% have strong fundamentals — momentum without quality, higher risk.
1 stocks sorted by market cap. Fundamentals = quality rating + growth flag. Hover for details.
| Stock? | Mkt Cap? | Status? | Valuation? | Weeks Outperforming Nifty 500? |
|---|---|---|---|---|
| 9.3K Cr | NEW THIS WK | No Data |
Based on publicly available financial data. This is educational research, not investment advice.
Currently, 1 stocks in the Ayurvedic sector are outperforming Nifty 500. This represents the sector's breadth — a higher count indicates broader sector participation in the market rally.
The Ayurvedic sector is expanding this week with a breadth change of +1 stocks.
The Ayurvedic stocks with the highest revenue growth
The Ayurvedic stocks with the highest profit growth
Earnings trend breakdown across Ayurvedic (1 stocks with data)
Ayurvedic shows mixed but improving signals — some stocks have strong fundamentals, worth selective study.
1 new stock entered the Ayurvedic outperformance list this week
Ayurvedic breadth trend over recent weeks
Here is the current fundamental and growth snapshot for Ayurvedic
The above FAQs are based on publicly available market data and financial metrics. This is educational research only for learning about sector and stock performance. Sector Alpha is not SEBI registered and does not provide investment advice or buy/sell recommendations.